دورية أكاديمية
CO22 Health-Related Quality of Life from a Phase 4 Global Clinical Study to Evaluate Discontinuation and Rechallenge of Pexidartinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) Previously Treated with Pexidartinib.
| العنوان: | CO22 Health-Related Quality of Life from a Phase 4 Global Clinical Study to Evaluate Discontinuation and Rechallenge of Pexidartinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) Previously Treated with Pexidartinib. |
|---|---|
| المؤلفون: | Desai, J.1 (AUTHOR), Wagner, AJ.2 (AUTHOR), Carrasco, Garcia I.3 (AUTHOR), Cesari, M.4 (AUTHOR), Gordon, M.5 (AUTHOR), Lin, CC.6 (AUTHOR), Papai, Z.7 (AUTHOR), Ryan, CW.8 (AUTHOR), Tap, WD.9 (AUTHOR), Trent, JC.10 (AUTHOR), Gelderblom, H.11 (AUTHOR), Grimison, P.12 (AUTHOR), López, Pousa A.13 (AUTHOR), Tine, Van.14 (AUTHOR), Dai, D.15 (AUTHOR), Rubinacci, M.15 (AUTHOR), Tecson, K.15 (AUTHOR), Wooddell, M.15 (AUTHOR), Stacchiotti, S.16 (AUTHOR) |
| المصدر: | Value in Health. 2024 Supplement, Vol. 27 Issue 6, pS20-S20. 1p. |
| قاعدة البيانات: | Academic Search Index |
| تدمد: | 10983015 |
|---|---|
| DOI: | 10.1016/j.jval.2024.03.111 |